/ THERAPEUTIC GOAL
Lower blood pressure
when medication reaches its limits
The goal of the treatment is to control resistant hypertension, a form of hypertension where blood pressure cannot be adequately lowered despite multiple medications.
/ Risk of high blood pressure
Hypertension is the leading risk factor
for cardiovascular disease
Despite drug therapy, blood pressure remains inadequately controlled in millions of people – with substantial consequences for the heart, brain, and other inner organs.1
33% of adults worldwide are affected by hypertension.1
Only 1 in 5 patients achieve target values with medication.1
Therapeutic resistance affects millions – with a high risk of myocardial infarction or stroke.1
1 World Health Organization (2023): Global report on hypertension: The race against a silent killer. ISBN 978-92-4-008106-2
/ ACTIVATE THE BAROREFLEX
Innovative approach
for therapy resistance
Our therapeutic approach uses targeted Vagus Nerve Stimulation (VNS) to reactivate natural blood pressure regulation in patients with treatment-resistant hypertension.
/ News
/ STUDY PARTICIPATION
Study participation:
Is the baroloop Multicenter Trial suitable for you?
Are you taking three or more antihypertensive medications – and your values are still too high?
For additional details on the baroloop study, please refer to clinicaltrials.gov, where you will also find a list of participating study centers.